scholarly journals Challenges in Cytology Specimens With Hürthle Cells

2021 ◽  
Vol 12 ◽  
Author(s):  
Eleni Thodou ◽  
Sule Canberk ◽  
Fernando Schmitt
Keyword(s):  
Malignant Tumors ◽  
Molecular Data ◽  
World Health ◽  
Thyroid Cytology ◽  
Precise Diagnosis ◽  
Bethesda System ◽  
Hurthle Cells ◽  
Health Organization ◽  
Hürthle Cells ◽  
The Bethesda System

In fine-needle aspirations (FNA) of thyroid, Hürthle cells can be found in a broad spectrum of lesions, ranging from non-neoplastic conditions to aggressive malignant tumors. Recognize them morphologically, frequently represents a challenging for an adequately diagnosis and are associated with a significant interobserver variability. Although the limitations of the morphologic diagnosis still exist, the interpretation of the context where the cells appear and the recent advances in the molecular knowledge of Hürthle cells tumors are contributing for a more precise diagnosis. This review aims to describe the cytology aspects of all Hürthle cells neoplastic and non-neoplastic thyroid lesions, focusing on the differential diagnosis and reporting according to The Bethesda System for Reporting Thyroid Cytology (TBSRTC). New entities according to the latest World Health Organization (WHO) classification are included, as well as an update of the current molecular data.

scholarly journals OVERVIEW ON ASSOCIATION OF DIFFERENT TYPES OF LEUKEMIAS WITH RADIATION EXPOSURE

2015 ◽  
Vol 37 (2) ◽  
pp. 89-93 ◽  
Author(s):  
D F Gluzman ◽  
L M Sklyarenko ◽  
M Zavelevich ◽  
S V Koval ◽  
T Ivanivskaya ◽  
...  
Keyword(s):  
Radiation Exposure ◽  
Hematological Malignancies ◽  
Causative Factor ◽  
World Health ◽  
Lymphoid Tissues ◽  
Different Types ◽  
Large Populations ◽  
Precise Diagnosis ◽  
Health Organization

Exposure to ionizing radiation is associated with increasing risk of various types of hematological malignancies. The results of major studies on association of leukemias and radiation exposure of large populations in Japan and in Ukraine are analyzed. The patterns of different types of leukemia in 295 Chernobyl clean-up workers diagnosed according to the criteria of up-to-date World Health Organization classification within 10–25 years following Chernobyl catastrophe are summarized. In fact, a broad spectrum of radiation-related hematological malignancies has been revealed both in Life Span Study in Japan and in study of Chernobyl clean-up workers in Ukraine. The importance of the precise diagnosis of tumors of hematopoietic and lymphoid tissues according to up-to-date classifications for elucidating the role of radiation as a causative factor of leukemias is emphasized. Such studies are of high importance since according to the recent findings, radiation-associated excess risks of several types of leukemias seem to persist throughout the follow-up period up to 55 years after the radiation exposure.

Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting

2017 ◽  
pp. 187-191
Author(s):  
Marta Penas-Prado
Keyword(s):  
Progression Free Survival ◽  
Scientific Meeting ◽  
Annual Scientific ◽  
Phase Iii ◽  
World Health ◽  
Annual Scientific Meeting ◽  
Tumor Treating Fields ◽  
Precise Diagnosis ◽  
Health Organization

The most relevant practice-changing presentations at the 2016 Society for Neuro-Oncology (SNO) Annual Scientific Meeting revolved around the topic of the new 2016 World Health Organization (WHO) classification of central nervous system (CNS) tumors. The most notable change in this new classification is the introduction of molecular markers into the morphologic classification of diffuse gliomas (isocitrate dehydrogenase [IDH] mutation, 1p19q codeletion, and H3K27M mutation), ependymomas (RELA fusion), medulloblastomas (WNT- and sonic hedgehog–activated), and other embryonal tumors (C19MC amplification), thus allowing for more precise diagnosis of these entities compared with the use of morphologic features alone. Among the clinical trials presented, only one phase III trial evaluating a device therapy for treatment of newly diagnosed glioblastoma (EF14; tumor-treating fields) met prespecified statistical criteria for success, showing a modest benefit in progression-free survival and overall survival in patients without progression after radiation and concurrent temozolomide. Other topics of interest included the spatial and temporal heterogeneity of primary brain tumors and the prevalence of burnout among neuro-oncologists.

scholarly journals TO STUDY THYROID CYTOLOGY BY CONVENTIONAL METHOD AND APPLYING BETHESDA SYSTEM TO SAME SMEARS.

2020 ◽  
Vol 4 (5) ◽  
Author(s):  
Krishan Kumar Sharma ◽  
Ashik Mullik
Keyword(s):  
Benign Lesion ◽  
Follicular Neoplasm ◽  
Predictive Values ◽  
Medical College ◽  
Thyroid Cytology ◽  
Prospective Group ◽  
Bethesda System ◽  
Sensitivity Specificity ◽  
Thyroid Cytopathology ◽  
The Bethesda System

Method: The thyroid cytology smears reported at the Department of Pathology Index medical College over a two year period from May 2015 to June 2017 and a prospective thyroid FNAC smears from Sep 2017 to Aug 2019 were studied at the Department of Pathology Index Medical College. The conventional and Bethesda system for reporting thyroid cytopathology were followed for reporting. A comparison of old conventional reporting system and Bethesda system were then analyzed.      Result: In Bethesda System None of the patients in both the group showed Inadequate diagnosis which was seen in the retrospective group using conventional system. Bethesda System has revealed that out of 81 patients with Benign Lesion, 41 (50.6%) were in retrospective group and 40 (49.4%) were in prospective group. Malignant was present in 2 (40%) and 3 (60%) patients in Retrospective and prospective group. Similarly out of 4 patients with Follicular Neoplasm, 3 (75%) and 1 (25%) were in retrospective and prospective group. However the distribution was comparable between both the groups. Conclusion: Adapting the Bethesda system of reporting has led to a high to sensitivity, specificity and high negative predictive values. Use of Bethesda systems helps in the prognosis, management and minimizes the unnecessary surgical procedures of thyroid swelling. Keywords: Thyroid, Cytology, Bethesda & Smears.

The 2004 WHO Classification of Non-Invasive Papillary Neoplasms of the Urinary Bladder (Also Referred to as WHO(2004)/ISUP)

2005 ◽  
Vol 72 (2) ◽  
pp. 224-228
Author(s):  
R. Mazzucchelli ◽  
R. Montironi ◽  
A. López Beltran ◽  
A.V. Bono
Keyword(s):  
Urinary Bladder ◽  
Clinical Studies ◽  
Who Classification ◽  
Molecular Data ◽  
Point Of View ◽  
World Health ◽  
Non Invasive ◽  
Health Organization ◽  
Risk Potential

The consistent use of the 2004 World Health Organization (WHO) classification of non-invasive urothelial papillary tumors should result in the uniform diagnosis of tumors diagnosis, stratified according to risk potential, and will facilitate comparative clinical studies, the incorporation of molecular data and the identification of aggressive, genetically unstable neoplasms. Until the 2004 WHO system is fully validated from the clinically and prognostically, point of view, tumors should be graded according to both the 2004 WHO scheme and the 1973 WHO system.

scholarly journals Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study

2018 ◽  
Vol 56 (2) ◽  
pp. 208-219 ◽  
Author(s):  
Ana Canadas ◽  
Miguel França ◽  
Cristina Pereira ◽  
Raquel Vilaça ◽  
Hugo Vilhena ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Malignant Tumors ◽  
Mammary Tumors ◽  
Classification Systems ◽  
World Health ◽  
Benign Tumors ◽  
Histological Subtype ◽  
Canine Mammary Tumors ◽  
Nottingham Grade ◽  
Health Organization

Histopathology remains the cornerstone for diagnosing canine mammary tumors (CMTs). Recently, 2 classification systems (the World Health Organization [WHO] classification of 1999 and the proposal of 2011) and 2 grading methods based on the human Nottingham grade have been used by pathologists. Despite some evidence that the histological subtype and grade are prognostic factors, there is no comprehensive comparative study of these classification and grading systems in the same series of CMTs. In this study, the 2 classifications and the 2 grading methods were simultaneously applied to a cohort of 134 female dogs with CMTs. In 85 animals with malignant tumors, univariable and multivariable survival analyses were performed. Using the 2 systems, the proportion of benign (161/305, 53%) and malignant (144/305, 47%) tumors was similar and no significant differences existed in categorization of benign tumors. However, the 2011 classification subdivided malignant tumors in more categories—namely, those classified as complex, solid, and tubulopapillary carcinomas by the WHO system. Histological subtype according to both systems was significantly associated with survival. Carcinomas arising in benign tumors, complex carcinomas, and mixed carcinomas were associated with a better prognosis. In contrast, carcinosarcomas and comedocarcinomas had a high risk of tumor-related death. Slight differences existed between the 2 grading methods, and grade was related to survival only in univariable analysis. In this cohort, age, completeness of surgical margins, and 2 index formulas adapted from human breast cancer studies (including tumor size, grade, and vascular/lymph node invasion) were independent prognostic factors.

Cytomorphologic, Imaging, Molecular Findings, and Outcome in Thyroid Follicular Lesion of Undetermined Significance/Atypical Cell of Undetermined Significance (AUS/FLUS): A Mini-Review

2018 ◽  
Vol 63 (1) ◽  
pp. 1-9 ◽  
Author(s):  
Bita Geramizadeh ◽  
Somayeh Bos-hagh ◽  
Zahra Maleki
Keyword(s):  
Needle Aspiration ◽  
American Thyroid Association ◽  
Atypical Cell ◽  
Thyroid Cytology ◽  
Bethesda System ◽  
Needle Aspiration Cytology ◽  
The Bethesda System ◽  
Ancillary Studies ◽  
Undetermined Significance

Objectives: Since the introduction of the entity of “Atypical cell of undetermined significance /follicular lesion of undetermined significance” (AUS/FLUS) by The Bethesda System for Reporting Thyroid Cytology (TBSRTC) in 2007, there have been many published studies about the cytomorphologic criteria, subclassification, outcome, and management of patients with the diagnosis of AUS/FLUS. There have been many studies in different aspects of this indeterminate category, i.e., cytologic and molecular findings, ultrasonographic findings, and in some instances even core-needle biopsy to address a better and safer way of the management of patients with this fine-needle aspiration cytology diagnosis. The second edition of TBSRTC and the 2015 American Thyroid Association guidelines provide an update on the follow-up and management of AUS/FLUS. A multidisciplinary team consisting of pathologists, endocrinologists, surgeons, and radiologists should be involved in the diagnosis and management of AUS/FLUS, and all of them should be aware of the heterogeneity of this lesion for the prediction of the treatment and outcome. Study Design: In this review, we consider different research platforms (2008–2017) to find the best and key reports for the above-mentioned challenging aspects of AUS/FLUS. Conclusion: AUS/FLUS is now a well-defined group of thyroid lesions, which can be most accurately diagnosed and managed with cytomorphology, molecular, and ancillary studies.

Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification

2016 ◽  
Vol 27 (2) ◽  
pp. 123-135 ◽  
Author(s):  
David S. Priemer ◽  
Rodolfo Montironi ◽  
Lisha Wang ◽  
Sean R. Williamson ◽  
Antonio Lopez-Beltran ◽  
...  
Keyword(s):  
World Health Organization ◽  
Neuroendocrine Tumors ◽  
Molecular Data ◽  
World Health ◽  
World Health Organization Classification ◽  
Health Organization

scholarly journals Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment

Cancers ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 758
Author(s):  
Yusuke Funakoshi ◽  
Nobuhiro Hata ◽  
Daisuke Kuga ◽  
Ryusuke Hatae ◽  
Yuhei Sangatsuda ◽  
...  
Keyword(s):  
Molecular Genetic ◽  
Molecular Data ◽  
Molecular Genetic Analysis ◽  
Cns Tumors ◽  
World Health ◽  
Biological Behavior ◽  
Cns Tumor ◽  
Health Organization ◽  
Prediction Of Prognosis

Recent research has promoted elucidation of the diverse biological processes that occur in pediatric central nervous system (CNS) tumors. Molecular genetic analysis is essential not only for proper classification, but also for monitoring biological behavior and clinical management of tumors. Ever since the 2016 World Health Organization classification of CNS tumors, molecular profiling has become an indispensable step in the diagnosis, prediction of prognosis, and treatment of pediatric as well as adult CNS tumors. These molecular data are changing diagnosis, leading to new guidelines, and offering novel molecular targeted therapies. The Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy (cIMPACT-NOW) makes practical recommendations using recent advances in CNS tumor classification, particularly in molecular discernment of these neoplasms as morphology-based classification of tumors is being replaced by molecular-based classification. In this article, we summarize recent knowledge to provide an overview of pediatric gliomas, which are major pediatric CNS tumors, and describe recent developments in strategies employed for their diagnosis and treatment.

scholarly journals Molecular Update and Evolving Classification of Large B-Cell Lymphoma

Cancers ◽  
2021 ◽  
Vol 13 (13) ◽  
pp. 3352
Author(s):  
Arantza Onaindia ◽  
Nancy Santiago-Quispe ◽  
Erika Iglesias-Martinez ◽  
Cristina Romero-Abrio
Keyword(s):  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Molecular Data ◽  
World Health ◽  
Molecular Features ◽  
Consensus Classification ◽  
Health Organization ◽  
Large B Cell

Diffuse large B-cell lymphomas (DLBCLs) are aggressive B-cell neoplasms with considerable clinical, biologic, and pathologic diversity. The application of high throughput technologies to the study of lymphomas has yielded abundant molecular data leading to the identification of distinct molecular identities and novel pathogenetic pathways. In light of this new information, newly refined diagnostic criteria have been established in the fourth edition of the World Health Organization (WHO) consensus classification of lymphomas, which was revised in 2016. This article reviews the histopathological and molecular features of the various aggressive B-cell lymphoma subtypes included in the updated classification.

Sign in / Sign up

Export Citation Format

Share Document